The Cigna Group (NYSE:CI) Position Reduced by Capital Planning Advisors LLC

Capital Planning Advisors LLC trimmed its stake in shares of The Cigna Group (NYSE:CI) by 75.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 801 shares of the health services provider’s stock after selling 2,502 shares during the quarter. Capital Planning Advisors LLC’s holdings in The Cigna Group were worth $221,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in The Cigna Group by 2.0% during the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock valued at $4,929,978,000 after acquiring an additional 279,880 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in The Cigna Group by 1.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 11,054,958 shares of the health services provider’s stock valued at $3,829,880,000 after acquiring an additional 130,048 shares during the last quarter. Geode Capital Management LLC boosted its stake in The Cigna Group by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 5,855,443 shares of the health services provider’s stock valued at $2,021,563,000 after acquiring an additional 22,408 shares during the last quarter. Parnassus Investments LLC raised its holdings in shares of The Cigna Group by 2.1% during the third quarter. Parnassus Investments LLC now owns 2,922,121 shares of the health services provider’s stock worth $1,012,340,000 after purchasing an additional 59,011 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of The Cigna Group by 2.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,168,959 shares of the health services provider’s stock worth $751,414,000 after purchasing an additional 44,810 shares during the period. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Stock Performance

Shares of CI opened at $290.02 on Thursday. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company has a 50-day moving average of $298.30 and a two-hundred day moving average of $326.03. The stock has a market cap of $80.67 billion, a price-to-earnings ratio of 27.34, a PEG ratio of 0.78 and a beta of 0.54. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same period last year, the company posted $6.77 earnings per share. The business’s revenue for the quarter was up 29.8% on a year-over-year basis. On average, equities research analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

Wall Street Analyst Weigh In

CI has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Piper Sandler reissued an “overweight” rating and set a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Truist Financial lowered their target price on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Barclays raised their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Stephens reissued an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a research note on Friday, November 1st. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and an average price target of $395.93.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.